Peripheral Artery Disease

Cardiovascular·MeSH: Peripheral Arterial Disease

6 drugs in development·6 companies·8 clinical trials

Drug Pipeline by Phase

Phase 3(3)

Drug	Company
human acellular vessel	Humacyte Inc. (HUMA)
plx-pad	Pluri Inc. (PLUR)
virtue sab	Orchestra BioMed Holdings Inc. (OBIO)

Phase 2(2)

Drug	Company
jan101	ALT5 Sigma Corp (ALTS)
regn9933	REGENERON PHARMACEUTICALS, INC. (REGN)

Preclinical(1)

Drug	Company
electroceuticals therapeutic devices	ENDONOVO THERAPEUTICS, INC. (ENDV)

BioSniper tracks 6 drugs in development for Peripheral Artery Disease across 6 companies.

There are 8 clinical trials targeting Peripheral Artery Disease tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.